Patents by Inventor ZHONGWEN YANG

ZHONGWEN YANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11952291
    Abstract: Disclosed is a device for efficiently recycling nickel from wastewater and a method. The device includes a housing, and an extraction unit and an electro-deposition unit which are respectively arranged inside the housing. The device is reasonable in overall structural design. An oscillating and floating component and a rotating component in an extraction cavity are used to fully and uniformly mix a solution to maximize the extraction strength. A mixing component in an electro-deposition cavity is used to accelerate ion dispersion, to better recycle nickel. The device is easy to operate, low in cost and suitable for mass promotion.
    Type: Grant
    Filed: March 30, 2023
    Date of Patent: April 9, 2024
    Assignee: Chongqing University Of Arts And Sciences
    Inventors: Wei Guan, Wen Zeng, Zhongwen Ou, Dan Song, Subo Yang, Yong Zhang, Bitao Liu, Zhigang Xie
  • Patent number: 10695347
    Abstract: The present invention provides a pyrimidine derivative and a use thereof. The pyrimidine derivative is the compound shown in formula I or a pharmaceutically acceptable salt, hydrate, solvate, metabolite or prodrug thereof, wherein, R1, R2, R3, R4 and R5 are, for example, as defined in the specification. The compound can act as an ALK inhibitor, and is for preparing an anti-tumor medicament for suppressing an anaplastic lymphoma kinase.
    Type: Grant
    Filed: November 4, 2016
    Date of Patent: June 30, 2020
    Assignee: HUBEI BIO-PHARMACEUTICAL INDUSTRIAL TECHNOLOGICAL INSTITUTE, INC.
    Inventors: Xuehai Wang, Yong Xu, Xijun Sheng, Xiaolin Zhang, Hangui Xia, Zhongwen Yang, Yang Yue, Lu Huang, Qiang Xiao
  • Patent number: 10662174
    Abstract: Provided are a series of BTK inhibitors, and specifically disclosed are a compound, pharmaceutically acceptable salt thereof, tautomer thereof or prodrug thereof represented by formula (I), (II), (III) or (IV).
    Type: Grant
    Filed: July 14, 2017
    Date of Patent: May 26, 2020
    Assignee: HUBEI BIO-PHARMACEUTICAL INDUSTRIAL TECHNOLOGICAL INSTITUTE, INC.
    Inventors: Xuehai Wang, Chengde Wu, Yong Xu, Chunli Shen, Li'e Li, Guoping Hu, Yang Yue, Jian Li, Diliang Guo, Nengyang Shi, Lu Huang, Shuhui Chen, Ronghua Tu, Zhongwen Yang, Xuwen Zhang, Qiang Xiao, Hua Tian, Yanping Yu, Hailiang Chen, Wenjie Sun, Zhenyu He, Jie Shen, Jing Yang, Jing Tang, Wen Zhou, Jing Yu, Yi Zhang, Quan Liu
  • Publication number: 20180338973
    Abstract: The present invention provides a pyrimidine derivative and a use thereof. The pyrimidine derivative is the compound shown in formula I or a pharmaceutically acceptable salt, hydrate, solvate, metabolite or prodrug thereof, wherein, R1, R2, R3, R4 and R5 are, for example, as defined in the specification. The compound can act as an ALK inhibitor, and is for preparing an anti-tumor medicament for suppressing an anaplastic lymphoma kinase.
    Type: Application
    Filed: November 4, 2016
    Publication date: November 29, 2018
    Inventors: Xuehai Wang, Yong Xu, Xijun Sheng, Xiaolin Zhang, Hangui Xia, Zhongwen Yang, Yang Yue, Lu Huang, Qiang Xiao
  • Publication number: 20170313683
    Abstract: Provided are a series of BTK inhibitors, and specifically disclosed are a compound, pharmaceutically acceptable salt thereof, tautomer thereof or prodrug thereof represented by formula (I), (II), (III) or (IV).
    Type: Application
    Filed: July 14, 2017
    Publication date: November 2, 2017
    Inventors: Xuehai Wang, Chengde Wu, Yong Xu, Chunli Shen, Li'e Li, Guoping Hu, Yang Yue, Jian Li, Diliang Guo, Nengyang Shi, Lu Huang, Shuhui Chen, Ronghua Tu, Zhongwen Yang, Xuwen Zhang, Qiang Xiao, Hua Tian, Yanping Yu, Hailiang Chen, Wenjie Sun, Zhenyu He, Jie Shen, Jing Yang, Jing Tang, Wen Zhou, Jing Yu, Yi Zhang, Quan Liu
  • Patent number: 9724374
    Abstract: A capsule containing total flavonoids of Desmodium styracifolium, a method for preparing the same and a use of the capsule containing total flavonoids of Desmodium styracifolium are provided. Specifically, the capsule includes total flavonoids of Desmodium Styracifolium provided in a form of alcohol extract of Desmodium Styracifolium and a pharmaceutically acceptable excipient.
    Type: Grant
    Filed: July 15, 2014
    Date of Patent: August 8, 2017
    Assignees: HUMANWELL HEALTHCARE (GROUP) CO., LTD., WUHAN OPTICS VALLEY HUMANWELL BIO-PHARMACEUTICAL CO., LTD., HUBEI BIOLOGICAL MEDICINE INDUSTRIAL TECHNOLOGY INSTITUTE CO., LTD., WUHAN CHEMLIGAND BIO-PHARMACEUTICAL CO., LTD.
    Inventors: Xuehai Wang, Yong Xu, Li'e Li, Jie Li, Ronghua Tu, Gang Chen, Rubin Cao, Yun Feng, Zhongwen Yang, Zhaoze Fan, Yanping Yu, Qiang Xiao, Lu Huang, Chengbing Yang, Tianci Huang, Hua Tian, Jing Yang
  • Publication number: 20170028007
    Abstract: A solid dispersion containing Desmodium Styracifolium (Osb.) Merr. flavonoids, method of preparing same and use thereof. The Desmodium Styracifolium (Osb.) Merr. flavonoids are alcohol extract of Desmodium Styracifolium (Osb.) Merr., and the solid dispersion is used for preparing a drug for treating urinary tract calculi.
    Type: Application
    Filed: July 15, 2014
    Publication date: February 2, 2017
    Inventors: XUEHAI WANG, LI'E LI, YONG XU, JIE LI, RONGHUA TU, GANG CHEN, RUBIN CAO, YUN FENG, ZHONGWEN YANG, ZHAOZE FAN, YANPING YU, QIANG XIAO, LU HUANG, CHENGBING YANG, TIANCI HUANG, HUA TIAN, JING YANG
  • Publication number: 20160303178
    Abstract: Disclosed are a pharmaceutical composition, a method for preparing the same and use thereof. The pharmaceutical composition consists of total flavonoids of Desmodium Styracifolium as an active ingredient and a pharmaceutically acceptable excipient. The pharmaceutical composition can be formulated in a form of a medicament formulation suitable to administration in clinic, and can be used in preparation of clinic treatment medicaments for treating dampness-heat and urinary stone (stagnation of dampness-heat).
    Type: Application
    Filed: July 15, 2014
    Publication date: October 20, 2016
    Inventors: XUEHAI WANG, JIE LI, LI'E LI, YONG XU, RONGHUA TU, GANG CHEN, RUBIN CAO, YUN FENG, ZHONGWEN YANG, ZHAOZE FAN, YANPING YU, QIANG XIAO, LU HUANG, CHENGBING YANG, TIANCI HUANG, HUA TIAN, JING YANG
  • Publication number: 20160296579
    Abstract: A capsule containing total flavonoids of Desmodium styracifolium, a method for preparing the same and a use of the capsule containing total flavonoids of Desmodium styracifolium are provided. Specifically, the capsule includes total flavonoids of Desmodium Styracifolium provided in a form of alcohol extract of Desmodium Styracifolium and a pharmaceutically acceptable excipient.
    Type: Application
    Filed: July 15, 2014
    Publication date: October 13, 2016
    Inventors: XUEHAI WANG, YONG XU, LI'E LI, JIE LI, RONGHUA TU, GANG CHEN, RUBIN CAO, YUN FENG, ZHONGWEN YANG, ZHAOZE FAN, YANPING YU, QIANG XIAO, LU HUANG, CHENGBING YANG, TIANCI HUANG, HUA TIAN, JING YANG